Lv3
270 积分 2023-07-19 加入
Development and characterization of a novel anti-OX40 antibody for potent immune activation
2个月前
已完结
Molecular Imaging: Principles and Practice
2个月前
已完结
A recombinant human enzyme for enhanced interstitial transport of therapeutics
3个月前
已完结
Efficient Xenoengraftment in Severe Immunodeficient NOD/Shi-scid IL2rγnull Mice Is Attributed to a Lack of CD11c+B220+CD122+ Cells
3个月前
已完结
Human PBMC-transferred murine MHC class I/II-deficient NOG mice enable long-term evaluation of human immune responses
3个月前
已完结
A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies
3个月前
已完结
Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons
6个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
6个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
7个月前
已完结
Targeting Distinct Epitopes of FCRL5 Using CAR-T Generated with Sequences Derived from Newly Identified FCRL5 Humanized Antibodies Resulted in Potent Anti-Myeloma Activity in Vitro and In Vivo
7个月前
已关闭
皖公网安备34019202002308
